Lewis Research Group

Synthetic Methodology & Natural Product Synthesis


Latest News

Research Aims

Group Members

About Simon




Simon Lewis was born in London in 1978. Aged 18 he lived for a year in Austria, where he worked for Novartis (then Sandoz). He returned to the UK to study chemistry at Imperial College London, working for a short period at Syngenta in Bracknell and gaining an MSci in chemistry. After some month spent working for GlaxoSmithKline in Dartford, he returned to Imperial to study for his Ph.D. with Prof. Donald Craig. His work concerned the Decarboxylative IrelandóClaisen rearrangement and its use in synthetic approaches to suaveoline, a pentacyclic indole alkaloid; the work was partially carried out at Pfizer in Sandwich. After gaining his Ph.D., Simon moved to the USA to work for Prof. Andrew G. Myers at Harvard University. This project was concerned with the synthesis of novel structural variants of the tetracycline antibiotics as potential treatments for drug-resistant infections. In 2008 he returned to the UK to take up an independent position at the University of Bath. In 2014 he was promoted to Senior Lecturer (Associate Professor).

He has been the recipient of scholarships from Syngenta (then Zeneca) and Pfizer and was jointly awarded the Neil Arnott Prize for the best graduating chemist of all colleges in the University of London. In 2013, he was awarded the University of Bath John Willis Award for dedication to the academic and personal lives of students combined with a significant contribution to teaching and accomplishment in research.

About Simon